Abstract
Three major types of rearrangements are involved in acute myeloid leukemias (AML): t(8;21)(q22;q22), inv(16)(p13q22), and 11q23/MLL abnormalities. Their precise identification becomes essential for diagnosis, prognosis, and therapeutic choices. Resulting fusion transcripts (FT) are also powerful markers for monitoring the efficacy of treatment, the minimal residual disease (MRD) and could become therapeutic targets. Today, the challenge is to propose an individual follow-up for each patient even for those with a rare fusion event. In this study, we propose a biochip-based assay integrated in a global strategy for identification of rare FT in AML, after fluorescence in situ hybridization detection, as described by the World Health Organization classification. Using cell lines, we developed and validated a biochip-based assay called the AMLFusionChip that identifies every FT of AML1-ETO, CBFbeta-MYH11 as well as MLL-AF9, MLL-ENL, MLL-AF6, and MLL-AF10. The original design of our AMLFusionChip.v01 enables the identification of these FT wherever the breakpoint on the partner gene may be. In case of biochip negative result, our 3'RACE amplification strategy enables to clone and then sequence the new translocation partner. This AMLFu...Continue Reading
References
Aug 1, 1976·British Journal of Haematology·J M BennettC Sultan
Oct 1, 1985·Annals of Internal Medicine·J M BennettC Sultan
Nov 1, 1995·Journal of Pediatric Hematology/oncology·J A Martinez-ClimentJ D Rowley
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J CorralA Karpas
Jun 1, 1996·British Journal of Haematology·I NilsonR Marschalek
Oct 31, 1996·Gene·D K NamJ J Yunis
May 1, 1997·Leukemia·R CostelloJ Gabert
Oct 23, 1997·Proceedings of the National Academy of Sciences of the United States of America·M D MegonigalC A Felix
Jun 25, 1998·Leukemia·C A Felix, D H Jones
Dec 22, 1999·Leukemia·J J van DongenA Biondi
Mar 8, 2000·American Journal of Clinical Pathology·M MitterbauerU Jaeger
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·M D MegonigalC A Felix
Jul 10, 2001·British Journal of Haematology·J BraessW Hiddemann
Dec 17, 2002·Leukemia & Lymphoma·Jennifer StulbergRichard A Wells
Jun 14, 2003·Leukemia & Lymphoma·Eiichi IshiiMariko Eguchi
Jun 14, 2003·Blood·Claudia SchochTorsten Haferlach
Jun 21, 2003·Clinical Chemistry·Run Zhang ShiJanet D Rowley
Oct 17, 2003·Leukemia·E BeillardJ Gabert
Oct 17, 2003·Leukemia·J GabertJ J M van Dongen
Jan 23, 2004·The Journal of Molecular Diagnostics : JMD·ShriHari S KadkolFarhad Ravandi
Aug 24, 2004·Leukemia·N MarocF Hermitte
Nov 6, 2004·Cancer Genetics and Cytogenetics·Mirjam KlausClaudia Schoch
Nov 16, 2004·Oncogene·Norbert VeyFrançois Bertucci
Jan 1, 2005·Proceedings of the National Academy of Sciences of the United States of America·Claus MeyerRolf Marschalek
May 18, 2005·Oncogene·Tomohiko TakiYasuhide Hayashi
Dec 13, 2005·Leukemia·L-Y ShihC-L Lai
Aug 8, 2006·Biotechnology Journal·Claus MeyerRolf Marschalek
Oct 21, 2006·Leukemia Research·Fumihiko MonmaHiroshi Shiku
Nov 25, 2006·Hematology·Miguel A Sanz
Mar 23, 2007·Leukemia·M WeisserS Schnittger
Sep 10, 2008·Blood·Janet D Rowley
Mar 6, 2009·Leukemia·C MeyerR Marschalek